Low Utilization of Beta-Blockers Among Medicare Beneficiaries Hospitalized for Heart Failure With Reduced Ejection Fraction
作者: Matthew Shane LoopMelissa K. van DykeLigong ChenMonika M. SaffordMeredith L. KilgoreTodd M. BrownRaegan W. DurantEmily B. Levitan
作者单位: 1Department of Biostatistics, University of North Carolina, Chapel Hill, North Carolina
2Center for Observational Research, Amgen, Thousand Oaks, California
3Department of Epidemiology, University of Alabama, Birmingham, Alabama
4Division of General Internal Medicine, Weill Cornell Medical College, New York, New York
5Department of Health Care Organization and Policy, University of Alabama, Birmingham, Alabama
6;Division of Cardiovascular Disease, University of Alabama, Birmingham, Alabama
7;Division of Preventive Medicine, University of Alabama, Birmingham, Alabama;
刊名: Journal of Cardiac Failure, 2019, Vol.25 (5), pp.343-351
来源数据库: Elsevier Journal
DOI: 10.1016/j.cardfail.2018.10.005
关键词: Medicare Part DCompeting risks
原始语种摘要: Abstract(#br)Background(#br)The evidence-based beta-blockers carvedilol, bisoprolol, and metoprolol succinate reduce mortality and hospitalizations among patients with heart failure with reduced ejection fraction (HFrEF). Use of these medications is not well described in the general population of patients with HFrEF, especially among patients with potential contraindications.(#br)Objectives(#br)Our goal was to describe the patterns of prescription fills for carvedilol, bisoprolol, and metoprolol succinate among Medicare beneficiaries hospitalized for HFrEF, as well as to estimate the associations between specific contraindications for beta-blocker therapy and those patterns.(#br)Methods and Results(#br)With the use of the cohort of 15,205 Medicare beneficiaries hospitalized for HFrEF from...
全文获取路径: Elsevier  (合作)
影响因子:3.32 (2012)

  • prescription 处方
  • blocker 间苗器
  • succinate 琥珀酸盐
  • hypotension 低血压
  • syncope 晕厥
  • metoprolol 美托洛尔
  • dosing 配量
  • evidence 
  • within 在以内
  • based 基于